nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—SLC7A5—Balsalazide—Sulfasalazine—rheumatoid arthritis	0.00851	0.451	CbGdCrCtD
L-DOPA—Mimosine—CCL2—rheumatoid arthritis	0.00836	0.277	CrCbGaD
L-DOPA—Isoprenaline—ADRBK1—rheumatoid arthritis	0.0039	0.129	CrCbGaD
L-DOPA—Masoprocol—ALOX5—rheumatoid arthritis	0.00329	0.109	CrCbGaD
L-DOPA—Epinephrine—ADRBK1—rheumatoid arthritis	0.00327	0.108	CrCbGaD
L-DOPA—Aminosalicylic Acid—ALOX5—rheumatoid arthritis	0.00305	0.101	CrCbGaD
L-DOPA—Mesalazine—ALOX5—rheumatoid arthritis	0.0024	0.0792	CrCbGaD
L-DOPA—Aminosalicylic Acid—MPO—rheumatoid arthritis	0.00197	0.0651	CrCbGaD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.00159	0.0839	CbGdCrCtD
L-DOPA—Mesalazine—MPO—rheumatoid arthritis	0.00154	0.0511	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—rheumatoid arthritis	0.00137	0.0726	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—rheumatoid arthritis	0.00129	0.0685	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—rheumatoid arthritis	0.00127	0.0674	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—rheumatoid arthritis	0.00127	0.0674	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—rheumatoid arthritis	0.00124	0.0659	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—rheumatoid arthritis	0.00118	0.0625	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—rheumatoid arthritis	0.00115	0.061	CbGdCrCtD
L-DOPA—Aminosalicylic Acid—PTGS2—rheumatoid arthritis	0.000738	0.0244	CrCbGaD
L-DOPA—Epinephrine—TNF—rheumatoid arthritis	0.000702	0.0232	CrCbGaD
L-DOPA—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000583	0.000949	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—rheumatoid arthritis	0.000581	0.000945	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—rheumatoid arthritis	0.000581	0.000945	CcSEcCtD
L-DOPA—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000579	0.000942	CcSEcCtD
L-DOPA—Mesalazine—PTGS2—rheumatoid arthritis	0.000579	0.0191	CrCbGaD
L-DOPA—Confusional state—Methylprednisolone—rheumatoid arthritis	0.000575	0.000936	CcSEcCtD
L-DOPA—Malaise—Betamethasone—rheumatoid arthritis	0.000573	0.000932	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—rheumatoid arthritis	0.000573	0.000932	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—rheumatoid arthritis	0.000572	0.00093	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—rheumatoid arthritis	0.00057	0.000927	CcSEcCtD
L-DOPA—Syncope—Betamethasone—rheumatoid arthritis	0.00057	0.000927	CcSEcCtD
L-DOPA—Arrhythmia—Prednisone—rheumatoid arthritis	0.000568	0.000924	CcSEcCtD
L-DOPA—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000568	0.000923	CcSEcCtD
L-DOPA—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000563	0.000916	CcSEcCtD
L-DOPA—Vomiting—Leflunomide—rheumatoid arthritis	0.000563	0.000916	CcSEcCtD
L-DOPA—Shock—Triamcinolone—rheumatoid arthritis	0.000563	0.000915	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—rheumatoid arthritis	0.000562	0.000915	CcSEcCtD
L-DOPA—Alopecia—Prednisone—rheumatoid arthritis	0.000562	0.000914	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—rheumatoid arthritis	0.000561	0.000913	CcSEcCtD
L-DOPA—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000559	0.000909	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000559	0.000909	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000559	0.000909	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000558	0.000908	CcSEcCtD
L-DOPA—Rash—Leflunomide—rheumatoid arthritis	0.000558	0.000908	CcSEcCtD
L-DOPA—Dermatitis—Leflunomide—rheumatoid arthritis	0.000558	0.000907	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—rheumatoid arthritis	0.000557	0.000906	CcSEcCtD
L-DOPA—Nausea—Azathioprine—rheumatoid arthritis	0.000557	0.000906	CcSEcCtD
L-DOPA—Headache—Leflunomide—rheumatoid arthritis	0.000555	0.000902	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000553	0.000899	CcSEcCtD
L-DOPA—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000553	0.000899	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000552	0.000897	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—rheumatoid arthritis	0.000551	0.000896	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—rheumatoid arthritis	0.000551	0.000896	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000549	0.000893	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—rheumatoid arthritis	0.000549	0.000893	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—rheumatoid arthritis	0.000549	0.000893	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000545	0.000887	CcSEcCtD
L-DOPA—Urticaria—Cyclosporine—rheumatoid arthritis	0.000543	0.000883	CcSEcCtD
L-DOPA—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00054	0.000879	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—rheumatoid arthritis	0.000539	0.000877	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—rheumatoid arthritis	0.000539	0.000877	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—rheumatoid arthritis	0.000535	0.00087	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—rheumatoid arthritis	0.000535	0.00087	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000535	0.000869	CcSEcCtD
L-DOPA—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000534	0.000869	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000533	0.000867	CcSEcCtD
L-DOPA—Pain—Prednisolone—rheumatoid arthritis	0.000532	0.000865	CcSEcCtD
L-DOPA—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000532	0.000864	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000528	0.000859	CcSEcCtD
L-DOPA—Nausea—Leflunomide—rheumatoid arthritis	0.000526	0.000855	CcSEcCtD
L-DOPA—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000525	0.000854	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000524	0.000853	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000524	0.000852	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—rheumatoid arthritis	0.000522	0.000849	CcSEcCtD
L-DOPA—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000521	0.000847	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—rheumatoid arthritis	0.000519	0.000845	CcSEcCtD
L-DOPA—Oedema—Betamethasone—rheumatoid arthritis	0.000519	0.000844	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—rheumatoid arthritis	0.000519	0.000844	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—rheumatoid arthritis	0.000517	0.000841	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000516	0.000839	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000514	0.000835	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000514	0.000835	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000512	0.000833	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000512	0.000833	CcSEcCtD
L-DOPA—Anaemia—Prednisone—rheumatoid arthritis	0.000512	0.000832	CcSEcCtD
L-DOPA—Shock—Dexamethasone—rheumatoid arthritis	0.000511	0.00083	CcSEcCtD
L-DOPA—Shock—Betamethasone—rheumatoid arthritis	0.000511	0.00083	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00051	0.000829	CcSEcCtD
L-DOPA—Agitation—Prednisone—rheumatoid arthritis	0.000509	0.000828	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000508	0.000826	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000508	0.000826	CcSEcCtD
L-DOPA—Angioedema—Prednisone—rheumatoid arthritis	0.000506	0.000823	CcSEcCtD
L-DOPA—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000504	0.000819	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000503	0.000819	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000502	0.000817	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000502	0.000816	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000502	0.000816	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000501	0.000814	CcSEcCtD
L-DOPA—Malaise—Prednisone—rheumatoid arthritis	0.000499	0.000812	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000497	0.000808	CcSEcCtD
L-DOPA—Syncope—Prednisone—rheumatoid arthritis	0.000497	0.000808	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—rheumatoid arthritis	0.000495	0.000804	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—rheumatoid arthritis	0.000495	0.000804	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—rheumatoid arthritis	0.000494	0.000803	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—rheumatoid arthritis	0.000493	0.000802	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000492	0.0008	CcSEcCtD
L-DOPA—Asthenia—Cyclosporine—rheumatoid arthritis	0.00049	0.000797	CcSEcCtD
L-DOPA—Pain—Triamcinolone—rheumatoid arthritis	0.000489	0.000795	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000487	0.000791	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—rheumatoid arthritis	0.000485	0.000789	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—rheumatoid arthritis	0.000485	0.000789	CcSEcCtD
L-DOPA—Pruritus—Cyclosporine—rheumatoid arthritis	0.000484	0.000786	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000483	0.000785	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.00048	0.000781	CcSEcCtD
L-DOPA—Convulsion—Prednisone—rheumatoid arthritis	0.00048	0.00078	CcSEcCtD
L-DOPA—Hypertension—Prednisone—rheumatoid arthritis	0.000478	0.000777	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000471	0.000766	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00047	0.000765	CcSEcCtD
L-DOPA—Anxiety—Prednisone—rheumatoid arthritis	0.00047	0.000764	CcSEcCtD
L-DOPA—Alopecia—Methotrexate—rheumatoid arthritis	0.00047	0.000764	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—rheumatoid arthritis	0.000469	0.000763	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—rheumatoid arthritis	0.000469	0.000763	CcSEcCtD
L-DOPA—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000468	0.00076	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000467	0.000759	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000466	0.000758	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000466	0.000758	CcSEcCtD
L-DOPA—Discomfort—Prednisone—rheumatoid arthritis	0.000466	0.000757	CcSEcCtD
L-DOPA—Mental disorder—Methotrexate—rheumatoid arthritis	0.000466	0.000757	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000458	0.000745	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000457	0.000743	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000457	0.000743	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—rheumatoid arthritis	0.000454	0.000739	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000453	0.000737	CcSEcCtD
L-DOPA—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000453	0.000737	CcSEcCtD
L-DOPA—Dizziness—Cyclosporine—rheumatoid arthritis	0.000452	0.000735	CcSEcCtD
L-DOPA—Oedema—Prednisone—rheumatoid arthritis	0.000452	0.000735	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000451	0.000734	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000451	0.000734	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000451	0.000734	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000448	0.000729	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000448	0.000729	CcSEcCtD
L-DOPA—Back pain—Methotrexate—rheumatoid arthritis	0.000448	0.000728	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000448	0.000728	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—rheumatoid arthritis	0.000447	0.000728	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—rheumatoid arthritis	0.000447	0.000728	CcSEcCtD
L-DOPA—Shock—Prednisone—rheumatoid arthritis	0.000445	0.000723	CcSEcCtD
L-DOPA—Liothyronine—ALB—rheumatoid arthritis	0.000444	0.0147	CrCbGaD
L-DOPA—Pain—Betamethasone—rheumatoid arthritis	0.000444	0.000722	CcSEcCtD
L-DOPA—Pain—Dexamethasone—rheumatoid arthritis	0.000444	0.000722	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000437	0.00071	CcSEcCtD
L-DOPA—Vision blurred—Methotrexate—rheumatoid arthritis	0.000436	0.000709	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000436	0.000709	CcSEcCtD
L-DOPA—Vomiting—Cyclosporine—rheumatoid arthritis	0.000435	0.000707	CcSEcCtD
L-DOPA—Rash—Cyclosporine—rheumatoid arthritis	0.000431	0.000701	CcSEcCtD
L-DOPA—Anorexia—Prednisone—rheumatoid arthritis	0.000431	0.000701	CcSEcCtD
L-DOPA—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000431	0.0007	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00043	0.000699	CcSEcCtD
L-DOPA—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000429	0.000698	CcSEcCtD
L-DOPA—Headache—Cyclosporine—rheumatoid arthritis	0.000428	0.000696	CcSEcCtD
L-DOPA—Anaemia—Methotrexate—rheumatoid arthritis	0.000428	0.000696	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000428	0.000695	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000428	0.000695	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000424	0.00069	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000424	0.00069	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000421	0.000685	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00042	0.000684	CcSEcCtD
L-DOPA—Malaise—Methotrexate—rheumatoid arthritis	0.000417	0.000679	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000416	0.000676	CcSEcCtD
L-DOPA—Leukopenia—Methotrexate—rheumatoid arthritis	0.000414	0.000674	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—rheumatoid arthritis	0.000412	0.00067	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—rheumatoid arthritis	0.000412	0.00067	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—rheumatoid arthritis	0.000411	0.000669	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—rheumatoid arthritis	0.00041	0.000667	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.00041	0.000667	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—rheumatoid arthritis	0.00041	0.000667	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000409	0.000666	CcSEcCtD
L-DOPA—Insomnia—Prednisone—rheumatoid arthritis	0.000409	0.000665	CcSEcCtD
L-DOPA—Nausea—Cyclosporine—rheumatoid arthritis	0.000406	0.00066	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—rheumatoid arthritis	0.000406	0.00066	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—rheumatoid arthritis	0.000405	0.000658	CcSEcCtD
L-DOPA—Cough—Methotrexate—rheumatoid arthritis	0.000404	0.000657	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000404	0.000657	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000402	0.000653	CcSEcCtD
L-DOPA—Convulsion—Methotrexate—rheumatoid arthritis	0.000401	0.000652	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—rheumatoid arthritis	0.000398	0.000647	CcSEcCtD
L-DOPA—Chest pain—Methotrexate—rheumatoid arthritis	0.000394	0.000641	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—rheumatoid arthritis	0.000393	0.000639	CcSEcCtD
L-DOPA—Rash—Prednisolone—rheumatoid arthritis	0.000392	0.000638	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—rheumatoid arthritis	0.000392	0.000637	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00039	0.000635	CcSEcCtD
L-DOPA—Fatigue—Prednisone—rheumatoid arthritis	0.00039	0.000634	CcSEcCtD
L-DOPA—Headache—Prednisolone—rheumatoid arthritis	0.00039	0.000634	CcSEcCtD
L-DOPA—Discomfort—Methotrexate—rheumatoid arthritis	0.000389	0.000633	CcSEcCtD
L-DOPA—Constipation—Prednisone—rheumatoid arthritis	0.000386	0.000628	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000386	0.000628	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—rheumatoid arthritis	0.000383	0.000623	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000383	0.000622	CcSEcCtD
L-DOPA—Confusional state—Methotrexate—rheumatoid arthritis	0.000381	0.000619	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—rheumatoid arthritis	0.000381	0.000619	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—rheumatoid arthritis	0.000378	0.000615	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000377	0.000614	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000372	0.000606	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—rheumatoid arthritis	0.000372	0.000605	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—rheumatoid arthritis	0.000372	0.000605	CcSEcCtD
L-DOPA—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.00037	0.000601	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00037	0.000601	CcSEcCtD
L-DOPA—Nausea—Prednisolone—rheumatoid arthritis	0.000369	0.000601	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—rheumatoid arthritis	0.000367	0.000597	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—rheumatoid arthritis	0.000367	0.000597	CcSEcCtD
L-DOPA—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000365	0.000594	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—rheumatoid arthritis	0.000364	0.000591	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000363	0.00059	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—rheumatoid arthritis	0.000361	0.000587	CcSEcCtD
L-DOPA—Rash—Triamcinolone—rheumatoid arthritis	0.000361	0.000586	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00036	0.000586	CcSEcCtD
L-DOPA—Anorexia—Methotrexate—rheumatoid arthritis	0.00036	0.000585	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—rheumatoid arthritis	0.00036	0.000585	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000359	0.000585	CcSEcCtD
L-DOPA—Urticaria—Prednisone—rheumatoid arthritis	0.000359	0.000584	CcSEcCtD
L-DOPA—Headache—Triamcinolone—rheumatoid arthritis	0.000358	0.000583	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—rheumatoid arthritis	0.000357	0.000581	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—rheumatoid arthritis	0.000357	0.000581	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000355	0.000577	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000355	0.000577	CcSEcCtD
L-DOPA—Hypotension—Methotrexate—rheumatoid arthritis	0.000353	0.000574	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—rheumatoid arthritis	0.000343	0.000558	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—rheumatoid arthritis	0.000343	0.000558	CcSEcCtD
L-DOPA—Insomnia—Methotrexate—rheumatoid arthritis	0.000342	0.000556	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—rheumatoid arthritis	0.00034	0.000552	CcSEcCtD
L-DOPA—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000339	0.000552	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—rheumatoid arthritis	0.000339	0.000551	CcSEcCtD
L-DOPA—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000337	0.000548	CcSEcCtD
L-DOPA—Somnolence—Methotrexate—rheumatoid arthritis	0.000336	0.000546	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000333	0.000541	CcSEcCtD
L-DOPA—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000332	0.000541	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—rheumatoid arthritis	0.00033	0.000537	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—rheumatoid arthritis	0.00033	0.000537	CcSEcCtD
L-DOPA—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000328	0.000534	CcSEcCtD
L-DOPA—Rash—Betamethasone—rheumatoid arthritis	0.000327	0.000532	CcSEcCtD
L-DOPA—Rash—Dexamethasone—rheumatoid arthritis	0.000327	0.000532	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000327	0.000532	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—rheumatoid arthritis	0.000327	0.000532	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000326	0.00053	CcSEcCtD
L-DOPA—Fatigue—Methotrexate—rheumatoid arthritis	0.000326	0.00053	CcSEcCtD
L-DOPA—Headache—Dexamethasone—rheumatoid arthritis	0.000325	0.000529	CcSEcCtD
L-DOPA—Headache—Betamethasone—rheumatoid arthritis	0.000325	0.000529	CcSEcCtD
L-DOPA—Asthenia—Prednisone—rheumatoid arthritis	0.000324	0.000527	CcSEcCtD
L-DOPA—Pain—Methotrexate—rheumatoid arthritis	0.000323	0.000525	CcSEcCtD
L-DOPA—Pruritus—Prednisone—rheumatoid arthritis	0.00032	0.00052	CcSEcCtD
L-DOPA—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000311	0.000506	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—rheumatoid arthritis	0.000309	0.000503	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000309	0.000502	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—rheumatoid arthritis	0.000308	0.000501	CcSEcCtD
L-DOPA—Nausea—Betamethasone—rheumatoid arthritis	0.000308	0.000501	CcSEcCtD
L-DOPA—Urticaria—Methotrexate—rheumatoid arthritis	0.0003	0.000488	CcSEcCtD
L-DOPA—Dizziness—Prednisone—rheumatoid arthritis	0.000299	0.000486	CcSEcCtD
L-DOPA—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000299	0.000486	CcSEcCtD
L-DOPA—Vomiting—Prednisone—rheumatoid arthritis	0.000287	0.000467	CcSEcCtD
L-DOPA—Rash—Prednisone—rheumatoid arthritis	0.000285	0.000463	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—rheumatoid arthritis	0.000285	0.000463	CcSEcCtD
L-DOPA—Headache—Prednisone—rheumatoid arthritis	0.000283	0.00046	CcSEcCtD
L-DOPA—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000278	0.000453	CcSEcCtD
L-DOPA—Asthenia—Methotrexate—rheumatoid arthritis	0.000271	0.000441	CcSEcCtD
L-DOPA—Nausea—Prednisone—rheumatoid arthritis	0.000268	0.000437	CcSEcCtD
L-DOPA—Pruritus—Methotrexate—rheumatoid arthritis	0.000267	0.000435	CcSEcCtD
L-DOPA—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000258	0.00042	CcSEcCtD
L-DOPA—Dizziness—Methotrexate—rheumatoid arthritis	0.00025	0.000406	CcSEcCtD
L-DOPA—Vomiting—Methotrexate—rheumatoid arthritis	0.00024	0.000391	CcSEcCtD
L-DOPA—Rash—Methotrexate—rheumatoid arthritis	0.000238	0.000387	CcSEcCtD
L-DOPA—Dermatitis—Methotrexate—rheumatoid arthritis	0.000238	0.000387	CcSEcCtD
L-DOPA—Headache—Methotrexate—rheumatoid arthritis	0.000237	0.000385	CcSEcCtD
L-DOPA—Nausea—Methotrexate—rheumatoid arthritis	0.000224	0.000365	CcSEcCtD
L-DOPA—DRD2—Signaling Pathways—CX3CR1—rheumatoid arthritis	6.49e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—rheumatoid arthritis	6.48e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.43e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.42e-05	0.000191	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—rheumatoid arthritis	6.34e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD28—rheumatoid arthritis	6.33e-05	0.000188	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCL5—rheumatoid arthritis	6.26e-05	0.000186	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NOS3—rheumatoid arthritis	6.25e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2RB—rheumatoid arthritis	6.25e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD28—rheumatoid arthritis	6.24e-05	0.000186	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	6.23e-05	0.000185	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SPP1—rheumatoid arthritis	6.2e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.17e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CSF2—rheumatoid arthritis	6.16e-05	0.000183	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.05e-05	0.00018	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SYK—rheumatoid arthritis	6.03e-05	0.00018	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C5—rheumatoid arthritis	6.03e-05	0.00018	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CXCL8—rheumatoid arthritis	6.03e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR5—rheumatoid arthritis	6.03e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—MMP3—rheumatoid arthritis	6.02e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.96e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2RA—rheumatoid arthritis	5.94e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFATC1—rheumatoid arthritis	5.94e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.92e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—rheumatoid arthritis	5.9e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—C3—rheumatoid arthritis	5.89e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—rheumatoid arthritis	5.89e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.88e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL12—rheumatoid arthritis	5.84e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.84e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—rheumatoid arthritis	5.83e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—STAT1—rheumatoid arthritis	5.82e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.79e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.78e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.77e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL12—rheumatoid arthritis	5.77e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCL2—rheumatoid arthritis	5.76e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—rheumatoid arthritis	5.76e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6R—rheumatoid arthritis	5.74e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL10—rheumatoid arthritis	5.74e-05	0.000171	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—rheumatoid arthritis	5.72e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.72e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.7e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL5—rheumatoid arthritis	5.68e-05	0.000169	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR6—rheumatoid arthritis	5.67e-05	0.000169	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR5—rheumatoid arthritis	5.64e-05	0.000168	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CSF2—rheumatoid arthritis	5.6e-05	0.000167	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	5.55e-05	0.000165	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NCF2—rheumatoid arthritis	5.52e-05	0.000164	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—C3—rheumatoid arthritis	5.51e-05	0.000164	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LEP—rheumatoid arthritis	5.48e-05	0.000163	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MED1—rheumatoid arthritis	5.46e-05	0.000163	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.45e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SYK—rheumatoid arthritis	5.43e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SH2B3—rheumatoid arthritis	5.38e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TRAF6—rheumatoid arthritis	5.38e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.38e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SYK—rheumatoid arthritis	5.36e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GZMB—rheumatoid arthritis	5.34e-05	0.000159	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.33e-05	0.000159	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—rheumatoid arthritis	5.3e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.26e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—STAT1—rheumatoid arthritis	5.24e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP3—rheumatoid arthritis	5.23e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TYK2—rheumatoid arthritis	5.23e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—rheumatoid arthritis	5.23e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL2—rheumatoid arthritis	5.19e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL3—rheumatoid arthritis	5.19e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL2—rheumatoid arthritis	5.18e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FN1—rheumatoid arthritis	5.17e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6R—rheumatoid arthritis	5.17e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—STAT1—rheumatoid arthritis	5.17e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.16e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6ST—rheumatoid arthritis	5.15e-05	0.000153	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR5—rheumatoid arthritis	5.12e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL2—rheumatoid arthritis	5.11e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6R—rheumatoid arthritis	5.1e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL10—rheumatoid arthritis	5.09e-05	0.000152	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	5.08e-05	0.000151	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	5.08e-05	0.000151	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SAA1—rheumatoid arthritis	5.07e-05	0.000151	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2RA—rheumatoid arthritis	5.04e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTK2—rheumatoid arthritis	5.04e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.01e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—C3—rheumatoid arthritis	5e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NCF1—rheumatoid arthritis	4.97e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CD80—rheumatoid arthritis	4.96e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL5—rheumatoid arthritis	4.94e-05	0.000147	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CSF2—rheumatoid arthritis	4.86e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—rheumatoid arthritis	4.79e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD28—rheumatoid arthritis	4.78e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—rheumatoid arthritis	4.71e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP3—rheumatoid arthritis	4.71e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TYK2—rheumatoid arthritis	4.71e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP3—rheumatoid arthritis	4.65e-05	0.000138	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TYK2—rheumatoid arthritis	4.64e-05	0.000138	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL2—rheumatoid arthritis	4.61e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6R—rheumatoid arthritis	4.6e-05	0.000137	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—BGN—rheumatoid arthritis	4.57e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SPP1—rheumatoid arthritis	4.57e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.55e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTK2—rheumatoid arthritis	4.53e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.51e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.5e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTK2—rheumatoid arthritis	4.47e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.45e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR5—rheumatoid arthritis	4.45e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL5—rheumatoid arthritis	4.45e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL12—rheumatoid arthritis	4.41e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.41e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—rheumatoid arthritis	4.4e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL5—rheumatoid arthritis	4.39e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2RA—rheumatoid arthritis	4.38e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CSF2—rheumatoid arthritis	4.38e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.37e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.36e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—rheumatoid arthritis	4.35e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—C3—rheumatoid arthritis	4.35e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CSF2—rheumatoid arthritis	4.32e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—rheumatoid arthritis	4.31e-05	0.000128	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—rheumatoid arthritis	4.26e-05	0.000127	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	4.21e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TYK2—rheumatoid arthritis	4.19e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SPP1—rheumatoid arthritis	4.12e-05	0.000123	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.11e-05	0.000122	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOS3—rheumatoid arthritis	4.11e-05	0.000122	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SYK—rheumatoid arthritis	4.1e-05	0.000122	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.1e-05	0.000122	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SPP1—rheumatoid arthritis	4.06e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LEP—rheumatoid arthritis	4.05e-05	0.00012	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.04e-05	0.00012	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.03e-05	0.00012	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR5—rheumatoid arthritis	4e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—rheumatoid arthritis	4e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—STAT1—rheumatoid arthritis	3.95e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR5—rheumatoid arthritis	3.95e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.95e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—rheumatoid arthritis	3.92e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL2—rheumatoid arthritis	3.91e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—C3—rheumatoid arthritis	3.91e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6R—rheumatoid arthritis	3.9e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL10—rheumatoid arthritis	3.9e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2RA—rheumatoid arthritis	3.89e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—rheumatoid arthritis	3.86e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—C3—rheumatoid arthritis	3.86e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FN1—rheumatoid arthritis	3.82e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6ST—rheumatoid arthritis	3.8e-05	0.000113	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD80—rheumatoid arthritis	3.66e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL8—rheumatoid arthritis	3.64e-05	0.000108	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LEP—rheumatoid arthritis	3.64e-05	0.000108	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LEP—rheumatoid arthritis	3.59e-05	0.000107	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP3—rheumatoid arthritis	3.56e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.55e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—rheumatoid arthritis	3.48e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—rheumatoid arthritis	3.48e-05	0.000103	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—rheumatoid arthritis	3.46e-05	0.000103	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FN1—rheumatoid arthritis	3.44e-05	0.000102	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	3.43e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTK2—rheumatoid arthritis	3.42e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.42e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.41e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL2—rheumatoid arthritis	3.4e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6R—rheumatoid arthritis	3.39e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FN1—rheumatoid arthritis	3.39e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6ST—rheumatoid arthritis	3.38e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL5—rheumatoid arthritis	3.36e-05	9.99e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CSF2—rheumatoid arthritis	3.31e-05	9.84e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—rheumatoid arthritis	3.3e-05	9.81e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD80—rheumatoid arthritis	3.29e-05	9.81e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NFKB1—rheumatoid arthritis	3.26e-05	9.71e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—rheumatoid arthritis	3.26e-05	9.69e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD80—rheumatoid arthritis	3.25e-05	9.67e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAPK8—rheumatoid arthritis	3.21e-05	9.54e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—rheumatoid arthritis	3.13e-05	9.32e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	3.11e-05	9.25e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.09e-05	9.21e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TYK2—rheumatoid arthritis	3.09e-05	9.19e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—rheumatoid arthritis	3.09e-05	9.19e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL2—rheumatoid arthritis	3.06e-05	9.12e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6R—rheumatoid arthritis	3.05e-05	9.09e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—rheumatoid arthritis	3.03e-05	9.03e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	3.02e-05	9e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL2—rheumatoid arthritis	3.02e-05	8.99e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6R—rheumatoid arthritis	3.01e-05	8.97e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.98e-05	8.87e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.96e-05	8.81e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	2.96e-05	8.8e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C3—rheumatoid arthritis	2.95e-05	8.8e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TYK2—rheumatoid arthritis	2.78e-05	8.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	2.75e-05	8.19e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	2.74e-05	8.17e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	2.73e-05	8.12e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—rheumatoid arthritis	2.72e-05	8.09e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	2.69e-05	8.02e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL8—rheumatoid arthritis	2.69e-05	8.01e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	2.59e-05	7.72e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.58e-05	7.69e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—rheumatoid arthritis	2.57e-05	7.65e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—rheumatoid arthritis	2.56e-05	7.61e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	2.49e-05	7.4e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAT—rheumatoid arthritis	2.47e-05	7.35e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—rheumatoid arthritis	2.43e-05	7.24e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.42e-05	7.21e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NFKB1—rheumatoid arthritis	2.41e-05	7.16e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.39e-05	7.11e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAPK8—rheumatoid arthritis	2.37e-05	7.04e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	2.36e-05	7.03e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	2.31e-05	6.89e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	2.31e-05	6.88e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	2.31e-05	6.86e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	2.3e-05	6.85e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	2.28e-05	6.8e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	2.27e-05	6.76e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	2.24e-05	6.66e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	2.19e-05	6.52e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VEGFA—rheumatoid arthritis	2.18e-05	6.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.17e-05	6.45e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	2.16e-05	6.43e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.14e-05	6.36e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.13e-05	6.34e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	2.1e-05	6.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	2.1e-05	6.25e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	2.06e-05	6.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	2.06e-05	6.13e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	2.05e-05	6.09e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—rheumatoid arthritis	2e-05	5.97e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.97e-05	5.85e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.94e-05	5.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.83e-05	5.44e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.8e-05	5.37e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.78e-05	5.3e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1.75e-05	5.2e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	1.74e-05	5.17e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	1.65e-05	4.92e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—rheumatoid arthritis	1.65e-05	4.91e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.65e-05	4.91e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.64e-05	4.87e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.61e-05	4.79e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—rheumatoid arthritis	1.51e-05	4.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.5e-05	4.47e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	1.49e-05	4.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.48e-05	4.42e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	1.47e-05	4.36e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.44e-05	4.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.36e-05	4.06e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	1.36e-05	4.05e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	1.34e-05	3.99e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.31e-05	3.91e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	1.12e-05	3.34e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	1.03e-05	3.06e-05	CbGpPWpGaD
